Genworth Mortgage Insurance Australia Limited (ASX: GMA) – Stock Price Rise with Slump in Profit

fea  f fc bbbdff

Consolidated statement of Genworth, the mortgage insurance group, indicated a fall in profit by 52.8% for the first half year ending 30 June 2018 to $41.90 million from $88.66 million in previous corresponding period. The decline was reportedly driven by the adverse impact from 2017 Earnings Curve Review. Revenue from ordinary activities was down by $67.24 million as compared to $296.50 million revenue generated in previous half year ending 30 June 2017. While Gross written premium increased 46.4% to $266.8 million in 1H18 from $182.3 million in 1H17 following the establishment of its new insurance entity in Bermuda, the expense ratio increased from 25.9% in 1H17 to 32.9% in 1H18, reflecting a decline in new insurance written by 32.3%.

Despite the heavy cut in profits, the company continues to announce special dividend of $0.04 per share and $0.08 of interim dividend per share, entitled for distribution on 30 August 2018 to shareholders registered on 16 August 2018. Following the release of half yearly report, ASX:GMA stock rose by $0.120 or 4.461% to $2.81, while the stock has shown decline of 10.06% past one year.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

Sponsored ad by Kalkine

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here